Wu, Y. L., Fukuoka, M., Mok, T. S., Saijo, N., Thongprasert, S., Yang, J. C., . . . Rukazenkov, Y. (2018). Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study.
Chicago Style CitationWu, Yi Long, Masahiro Fukuoka, Tony S.K Mok, Nagahiro Saijo, Sumitra Thongprasert, James C.H Yang, Da Tong Chu, Jin Ji Yang, and Yuri Rukazenkov. Tumor Response and Health-related Quality of Life in Clinically Selected Patients From Asia With Advanced Non-small-cell Lung Cancer Treated With First-line Gefitinib: Post Hoc Analyses From the IPASS Study. 2018.
MLA引文Wu, Yi Long, et al. Tumor Response and Health-related Quality of Life in Clinically Selected Patients From Asia With Advanced Non-small-cell Lung Cancer Treated With First-line Gefitinib: Post Hoc Analyses From the IPASS Study. 2018.